Diarrhea and flushing were reported by 62 patients (91.1%), one patient (1.5%) had an adrenocorticotropic hormone (ACTH)-producing gastrointestinal neuroendocrine tumor, and five (7.4%) had insulin-producing disease. This evidence concerns the gene INS and digestive system neuroendocrine tumor, grade 1/2.